New form of a known substance" often meant big companies just changing a salt or crystal to extend patents and keep prices high—we call that evergreening. The Glivec judgment by our Supreme Court was a blessing, shukriya, because it said such small changes without real therapeutic benefit cannot be patented. This protected our right to make affordable generics for patients. I see it in my own mother's medicine—when the patent ended, we could produce it and her tension eased, because our family could finally afford it.
#athletics#track-and-field
Jump in to reply — no account needed.